Physician profile
Ali Catherine Devine
NPI 1730833492
$1,815.47
in general payments reported to CMS, 2019-2025
12 companies · $510 in 2025
The $510 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $348 · 2023: $566 · 2024: $392 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,467.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $557.43 | 2022-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $386.70 | 2022-2025 | Rybelsus, Ozempic, Tresiba |
| Dexcom, INC. | $279.16 | 2022-2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Cequr Corporation | $146.10 | 2024-2025 | Cequr Simplicity |
| Beta Bionics, INC. | $128.31 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Corcept Therapeutics | $98.66 | 2023 | Korlym |
| Medtronic, INC. | $74.32 | 2024 | Minimed 780g |
| Lilly USA, LLC | $45.06 | 2025 | Mounjaro |
| Xeris Pharmaceuticals, INC. | $37.95 | 2025 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.17 | 2023-2024 | Jardiance |
| Ascensia Diabetes Care US INC. | $14.40 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Devine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.